纤维细胞激活蛋白抑制剂 (FAPI) PET成像在肉瘤:核医学的一个新前沿
Francesco Giammarile1, Peter Knoll1, Diana Paez1
1Department of Nuclear Science and Applications, Nuclear Medicine and Diagnostic Imaging Section, International Atomic Energy Agency, Vienna, Austria.
Seminars in nuclear medicine
|February 16, 2024
概括
纤维细胞激活蛋白抑制剂 (FAPI) PET成像显示出诊断和监测瘤的前景. 需要进一步的研究来解决瘤异质性问题,并优化FAPI PET协议用于肉瘤患者.
科学领域:
- 核医学是一种核医学.
- 在瘤学瘤学.
- 无线电探测器的发展发展.
背景情况:
- 在PET成像方面取得了重大进展.
- 纤维细胞激活蛋白抑制剂 (FAPI) 成为新的放射性追踪剂.
- 在包括瘤在内的各种恶性瘤中,FAPI PET显示出有前途.
研究的目的:
- 探索FAPI PET成像在肉瘤诊断中的潜力.
- 评估FAPI PET用于瘤分期.
- 评估FAPI PET用于对瘤的治疗监测.
主要方法:
- 在肉瘤中对FAPI PET进行研究的综述.
- 与治疗结果相关的FAPI吸收的分析.
- 考虑诸如肉瘤异质性之类的挑战.
主要成果:
- FAPI PET在瘤中显示出潜在的作用.
- 吸收FAPI的变化与治疗反应相关.
- 瘤异质性可能会影响FAPI表达.
结论:
- FAPI PET成像是核医学和瘤学的重大进步.
- 向FAP为肉瘤诊断和治疗提供了新的可能性.
- 目前正在进行的研究旨在克服局限性并优化FAPI PET用于临床使用.
相关概念视频
Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):


![An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F66708.jpg&w=3840&q=50)